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Abstract
Objectives We investigated the relationship between white-
matter alteration and cognitive status in Parkinson’s disease
(PD) with and without dementia by using diffusion tensor
imaging.
Methods Twenty PD patients, 20 PDD (Parkinson’s disease
with dementia) patients and 20 age-matched healthy con-
trols underwent diffusion tensor imaging. The mean diffu-
sivity and fractional anisotropy (FA) map of each patient
group were compared with those of the control group by
using tract-based spatial statistics. Tractography images of
the genu of the corpus callosum fibre tracts were generated,
and mean diffusivity and FA were measured.
Results FA values in many major tracts were significantly
lower in PDD patients than in control subjects; in the pre-
frontal white matter and the genu of the corpus callosum
they were significantly lower in PDD patients than in PD
patients. There was a significant correlation between the
Mini-Mental State Examination (MMSE) scores and the
FA values of the prefrontal white matter and the genu of
the corpus callosum in patients with PD.
Conclusions Our study shows a relationship between cogni-
tive impairment and alteration of the prefrontal white matter
and genu of the corpus callosum. These changes may be
useful in assessing the onset of dementia in PD patients.
Key Points
• Dementia is a common and important non-motor sign of
Parkinson’s disease (PD).
• The neuropathological basis of dementia in PD is not
clear.
• DTI shows abnormalities in the prefrontal white matter in
PD with dementia.
• Prefrontal white matter alteration may be useful biomarker
of dementia in PD.
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Introduction
Dementia, one of the most common and important non-
motor signs of Parkinson’s disease (PD), greatly affects
functioning and quality of life [1]. Cognitive impairment
in PD occurs even at the early stage [2], and a recent
longitudinal study that followed newly diagnosed PD
patients for 20 years suggests that up to 80 % will develop
dementia [3]. However, despite the clinical importance of
dementia, its neuropathological basis in PD remains contro-
versial [4].
According to the hypothesis proposed by Braak et al. [5],
deposition of Lewy bodies and Lewy neurites, which path-
ologically characterises PD, begins in the brain stem,
spreads to the forebrain and limbic system, and finally
reaches the neocortex. The pathological characteristics are
divided into six subgroups according to the deposition of the
Lewy bodies. These stages and the progression of cognitive
impairment occur in parallel [6].
Many demographic and clinical characteristics have been
evaluated as potential risk factors for the development of
dementia in PD. Advanced age, relatively severe parkinson-
ism and mild cognitive impairment [7] have been identified
as risk factors in several longitudinal studies [8]. Although
demographic and clinical characteristics can be used to help
estimate variations in the rate of cognitive decline and time
to dementia in PD, objective biomarkers (such as magnetic
resonance imaging [MRI] findings) are also needed.
In structural MRI studies, patients who have Parkinson’s
disease with dementia (PDD) have atrophy of the parieto-
temporal lobe, entorhinal cortex, hippocampus, prefrontal
cortex and posterior cingulate, unlike PD patients without
dementia or healthy controls [9–11].
There have also been reports of a relationship between
cognitive status and white-matter alteration as determined
by using diffusion tensor imaging (DTI). DTI can be used to
measure the characteristics of local microstructural water
diffusion in brain tissue. One representative diffusion tensor
parameter is FA, which describes the degree of water mol-
ecule anisotropy or the directional preference of the water
diffusion process. FA values in white matter are determined
mainly by the cytoskeleton of the neurofilaments and micro-
tubules and by the axonal membrane [12]. FA abnormalities
in the brain are interpreted pathologically as being caused by
loss of neurons or glia, by gliosis or demyelination [13], or
by loss of the structural integrity of the white matter (i.e.
white-matter damage) [14] Wiltshire et al. [15] reported a
significant correlation between Mini-Mental State Examina-
tion (MMSE) score and mean diffusivity (MD) within the
corpus callosum, Matsui et al. [16] reported that decreased
fractional anisotropy (FA) values in the parietal white matter
are associated with executive dysfunction, and Hattori et al.
[14] reported that FA values in the parietal white matter
significantly correlated with MMSE scores in patients with
PD.
Wiltshire et al. [15] used tractography in their analysis,
whereas Matsui et al. [16] used the region of interest (ROI)
method. Both tractography and the ROI method have limita-
tions in that their analytical domains are confined to fixed
areas and it is difficult to prevent analyst bias. Hattori et al.
used tract-based spatial statistics (TBSS) to perform a whole-
brain analysis; for DTI they used 1.5-T MRI with a relatively
small number of motion probing gradient (MPG) axes [12].
From these previous studies, we hypothesised that the
changes in white matter in PDD patients are linked to
cognitive impairment. We therefore performed a whole-
brain analysis by using TBSS; for the DTI we used 3-T
MRI, and we increased the number of MPG axes to 32 in an
effort to overcome the limitations of previous studies.
After detecting specific white-matter alterations by using
the TBSS method, we performed a more detailed investiga-
tion of the alteration by using tractography.
Materials and methods
Subjects
This study was approved by an institutional review board;
informed consent was obtained from all participants before
evaluation. For subjects who were deemed by the clinician
not to have the capacity to give consent, a legally authorised
surrogate provided consent.
There were 60 subjects: 20 PD patients, 20 PDD patients
and 20 healthy controls. Note that some of these patients had
also participated in our previous study [17]. All PD patients
had been diagnosed by neurologists and met the United
Kingdom Parkinson’s Disease Society Brain Bank criteria
[18]. PD was staged according to the Hoehn and Yahr scale,
and the subjects underwent the Japanese version of the
MMSE to assess cognitive dysfunction [19]. PDD was
diagnosed in accordance with recently published guidelines
[20], and patients with probable PDD were selected. All PD
and PDD patients were taking levodopa (Table 1) at the time
of the MRI and clinical examination.
Twenty-four months or more after MRI, all of the patients
remained free of atypical parkinsonism and continued
responding satisfactorily to anti-parkinsonian therapy. The
20 normal control subjects were recruited from the general
population and were carefully matched by age with the
patients. Individuals with any history of hypertension, dia-
betes mellitus, cardiovascular disease, stroke, brain tumour,
epilepsy, Parkinson’s disease, dementia, depression, drug
abuse or head trauma were excluded as controls.
The demographic characteristics of the subjects are shown
in Table 1.
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MRI
MRI was performed at 3-T (Achieva; Philips Medical Sys-
tems, Best, The Netherlands) using an eight-channel phased-
array head coil for sensitivity encoding parallel imaging.
Conventional MR images, such as T1-weighted spin echo
images, T2-weighted turbo-spin echo images and fluid-
attenuated inversion recovery images, were obtained before
acquisition of the diffusion tensor images. DTI was performed
by using the spin-echo echo-planar technique (TR/TE
5,443/70 ms, matrix size 128×128, field of view 224×
224 mm2, slice thickness 3 mm with no gap). Images were
obtained with both 32-direction diffusion-encoding (b=
1,000 s/mm2 for each direction) and no diffusion encoding
(b=0 s/mm2). A total of 50 axial section images were
obtained, covering the whole cerebrum. MR data acquisition
time was 7 min 17 s.
DTI image processing using TBSS
Voxel-based analysis of the DTI data was performed using
TBSS (tract-based spatial statistics) [21] implemented with
the FMRIB Software Library 4.1.5 (FSL, Oxford Centre for
Functional MRI of the Brain, UK; www.fmrib.ox.ac.uk/fsl),
After eddy current correction and brain extraction had been
performed, FA and MD images for all subjects were created
by fitting a tensor model to the raw diffusion data. FA
images of all subjects were aligned in standard Montreal
Neurological Institute (MNI152) space by using FNIRT, a
non-linear registration tool that uses a B-spline representa-
tion of the registration warp field .
Next, the mean FA image was created and thinned to
create the mean FA skeleton, which represented the centres
of all tracts common to the groups. The mean FA skeleton
was thresholded to FA>0.20 to include the major white-
matter pathways but exclude peripheral tracts and grey
matter. Each subject’s aligned FA map was then projected
onto this skeleton by assigning to each point on the skeleton
the maximum FA in a plane perpendicular to the local
skeleton structure. The resulting skeletons were fed into
voxel-wise statistics.
By applying the original non-linear registration of each
subject’s FA to the standard space, the MD was also pro-
jected onto the mean FA skeleton. The MD data were also
used to calculate voxel-wise statistics.
Voxel-wise statistics of the skeletonised FA data were ap-
plied by using Randomise (part of FSL) to test for group
differences between the patient and control groups. Randomise
performed permutation-based testing with 5,000 permutations
and inference by using TFCE (threshold-free cluster enhance-
ment) [22] with a threshold of P<0.05, corrected for multiple
comparisons by using the family-wise error correction.
Randomise was also used to examine the relationship
between FA/MD and MMSE score, disease duration,
Hoehn–Yahr stage, levodopa dosage in the PD and PDD
patients group separately and combined, by using multiple
linear regression analysis (P<0.05, corrected for gender and
age at the time of MRI).
The anatomical locations of regions with significant
group differences in FA and MD on the white-matter skel-
eton were identified by using a white-matter atlas [23].
DTI image processing using tract-specific analysis
DTI data were transferred to an offline workstation. Maps of
FA and MD were computed by using dTV II and VOLUME-
ONE 1.72, developed by Masutani et al. [24] (University of
Tokyo; diffusion tensor visualiser available at http://
www.volume-one.org/), Diffusion tensors were computed,
and fibre tracts were created by using interpolation along the
z-axis to obtain data (voxel size 2.0×2.0×3.0 mm3). Colour-
coded maps were created by using 33 sets of images (32 sets
with b=1,000 s/mm2, 1 set with b=0 s/mm2). On the colour
maps, red was assigned to left–right, green to anteroposterior
and blue to the craniocaudal direction. Fibre tracts were based
on the fibre assignment made by using the continuous tracking
Table 1 Demographic characteristics of the subjects
Control (n=20) PD (n=20) PDD (n=20) P value
Sex, male : female 10 : 10 8 : 12 10 : 10 NS
Age in years, mean (SD) 72.7 (3.3) 71.6 (4.3) 71.7 (5.3) NS
Disease duration in months, mean (SD) NA 94.0 (53.4) 146.6 (91.0) <0.05 (PD vs PDD)
Hoehn–Yahr stage (SD) 0 2.4 (1.0) 2.9 (0.7) <0.05 (PD vs PDD)
MMSE (SD)a 28.8 25.7 (3.2) 18.7 (5.8) <0.01 (PD vs PDD)
Levodopa dosage mg/day, median (SD) 0 464.2 (175.0) 673.3 (120.0) <0.05 (PD vs PDD)
PD Parkinson’s disease, PDD Parkinson’s disease with dementia,MMSEMini-Mental State Examination, NA not applicable, NS not significant
(P>0.05)
aMMSE scores were significantly lower in PDD patients than in controls (P<0.01) or PD patients (P<0.01), but the scores did not differ
significantly between controls and PD patients
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approach [25] to obtain a three-dimensional tract reconstruc-
tion. Identification of fibre tracts was initiated by placing a
seed area in anatomical regions through which the particular
fibres were expected to course [26]. Tract measurements were
performed by two of the authors (K.S., K.K.), who were
blinded to the disease status of the subjects.
Tractography of the genu of the corpus callosum was per-
formed according to Hofer and Frahm’s scheme [27], as the
most anterior segment covers the first sixth of the corpus
callosum and contains fibres projecting into the prefrontal
region (Hofer and Frahm defined CC1). The seed ROI was
placed manually, including the entirety of the genu of the
corpus callosum (light blue area), on a reconstructed mid-
sagittal image with a non-diffusion-weighted image (b=
0 s/mm2) (Fig. 1a). Tractographic images of the genu of the
corpus callosum were generated with threshold values of line-
tracking termination FA>0.18 (Fig. 1b). The genu of the corpus
callosum fibre tracts was defined as follows: anterior–posterior,
including the first sixth of the corpus callosum; above and
below, including the upper and lower border of the genu of
the corpus callosum; and right–left, between the anterior horns
of the lateral ventricles (Fig. 1c, d). Voxelisation along the genu
of the corpus callosum was then performed. To reduce the
partial volume effect of the peripheral portion of the tract and
to eliminate small incidental artefactual lines, we used a shape-
processing technique based on mathematical morphology [28].
In this shape-processing technique, we dilated the voxels once
and eroded twice. FA and MD values in co-registered voxels
were calculated (Fig. 1e).
Statistical analysis
Statistical analysis of demographic and clinical data was
performed by using analysis of variance with Tukey’s
HSD (honestly significant difference) test for continuous
variables and a χ2 test for categorical data. The criterion of
statistical significance was P<0.05. Statistical analyses were
performed with SPSS for Windows, Release 8.0.
We used the Kolmogorov-Smirnov test for analysis of
normal distribution. Because only the MD of the PD group
was not normally distributed, we used non-parametric (Krus-
kal-Wallis) analysis of variance and the Mann–WhitneyU test
to test for differences between groups. A Bonferroni correc-
tion was applied for the number of comparisons (n=3: [nor-
mal vs PD, normal vs PD, PD vs PDD], setting the level of
significance at P<0.05/3=0.016).
Fig. 1 Diffusion tensor tractography images of the genu of the corpus
callosum and fibre tracts, and voxelisation. a The seed region of
interest was placed manually including the entire genu of the corpus
callosum (light blue area) on a reconstructed mid-sagittal image with a
non-diffusion-weighted image (b=0 s/mm2). b Tractographic image of
the genu of the corpus callosum was generated with threshold values of
line-tracking termination as fractional anistropy (FA)>0.18. c, d Fibre
tracts of the genu of the corpus callosum were defined as follows:
anterior–posterior, including the first sixth of the corpus callosum;
above and below, including the upper and lower border of the genu
of the corpus callosum; right–left, between the anterior horns of the
lateral ventricles. e Voxelisation was performed along the genu of the
corpus callosum (blue voxels). FA and mean diffusivity (MD) values in
co-registered voxels were calculated
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Spearman’s rank-order correlation test was used to inves-
tigate correlations between the imaging measurements and
continuous clinical variables.
Results
Demographic and clinical features
The three groups did not differ by age (P>0.70, ANOVA) or
gender (P>0.76, χ2) (Table 1). As expected, PDD patients
scored significantly lower than PD patients and control
subjects on the MMSE (P<0.01, P<0.01, ANOVA with
Tukey’s HSD test), but PD and control subjects did not
differ significantly on the MMSE. There were significant
differences in disease duration, Hoehn–Yahr stage, and
levodopa dosage (mg/day) between PD and PDD patients
(Table 1).
White-matter alteration assessed by using TBSS
FA and MD values were not significantly altered in the
cerebral white matter of patients with PD compared with
control subjects.
In patients with PDD, major white-matter tracts had
significantly reduced FA values compared with the control
group (Fig. 2a). The affected white-matter tracts included
the superior and inferior longitudinal fasciculus, the inferior
fronto-occipital fasciculus, the uncinate fasciculus, the cin-
gulum, the anterior limb of the internal capsule and the
substantia nigra. The reductions in FA were seen bilaterally
in all of the affected white-matter tracts. Increased MD was
found in major white-matter tracts in the PDD patients
compared with the control group (Fig. 2b). MD was in-
creased in almost the same white-matter tracts as those in
which FA was decreased; in addition, MD was increased in
the posterior limb of the internal capsule.
Fig. 2 Corrected P maps. Tract-based spatial statistics (TBSS) analy-
sis of the FA of normal control vs Parkinson’s disease with dementia
(PDD) (a), MD of normal controls vs PDD (b), FA of Parkinson’s
disease (PD) vs PDD (c), MD of PD vs PDD (d). All images are
displayed in Montreal Neurological Institute space. a TBSS analysis
demonstrated significantly decreased FA (red–yellow voxels) in several
major white-matter tracts in the PDD group compared with the control
group. b MD was increased in almost the same white-matter tracts as
those in which FAwas decreased in the PDD group compared with the
control group (blue-light blue voxels). c In patients with PDD, FA
values in the anterior part of the inferior fronto-occipital fasciculus
(i.e. the white matter adjacent to the prefrontal area) and in part of the
genu of the corpus callosum were significantly lower than those in PD
patients (red-yellow voxels). d MD was increased in almost the same
white-matter tracts as those in which FAwas decreased in PDD patients
relative to PD patients (blue-light blue voxels)
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In patients with PDD, FAvalues in the anterior part of the
inferior fronto-occipital fasciculus (i.e. the white matter
adjacent to the prefrontal area) and in part of the genu of
the corpus callosum were significantly lower than in PD
patients (Fig. 2c). MD was increased in almost the same
white-matter tracts as those in which FA was decreased in
PDD patients relative to PD patients (Fig. 2d).
In the PD and PDD groups combined, FA values corre-
lated with MMSE scores. FA correlated positively with
MMSE score in the anterior part of the inferior fronto-
occipital fasciculus, in part of the genu of the corpus cal-
losum bilaterally, and in smaller areas in the right anterior
and left posterior parts of the superior longitudinal fascicu-
lus (precuneus) and in the left part of the corpus callosum
(Fig. 3). FA and MD did not correlate with MMSE score in
the separate PD and PDD groups. In the PD group, the PDD
group, and the combined PD and PDD group, FA and MD
did not correlate with disease duration, Hoehn–Yahr stage or
levodopa dosage.
Because in PDD the FA values in the white matter adja-
cent to the prefrontal area and in part of the genu of the
corpus callosum were significantly decreased and correlated
positively with MMSE scores, we hypothesised that the
genu of the corpus callosum, which contains fibres projec-
ting into the prefrontal area, is involved in the pathological
processes responsible for dementia in PD. We therefore
compared diffusion abnormalities in the genu of the corpus
callosum in PDD and PD patients with those in normal
controls using diffusion tensor tractography.
White-matter alteration assessed by using tract-specific
analysis
Reproducibility was determined on the basis of fibre counts
and expressed as an intraclass correlation coefficient; the
coefficient was 0.96 for the genu of the corpus callosum.
Averaged values were therefore used for further statistical
analyses.
There was a significant correlation between MMSE score
and FA and MD values in the genu of the corpus callosum
(FA: r=0.472; MD: r=−0.453, P<0.005) in the PD and
PDD patient groups combined (Fig. 4). FA and MD did
not correlate with MMSE score in the separate PD and
PDD groups (FA in the PD group: r=0.303, P=0.194; MD
in the PD group: r=−0.165, P=0.488; FA in the PDD group:
r =0.313, P=0.178; MD in the PDD group: r=−0.223, P=
0.344). However, we did observe a trend toward a positive
correlation between FA in the genu of the corpus callosum
and MMSE score. FA and MD values of the genu of the
corpus callosum did not correlate significantly with disease
duration or Hoehn–Yahr stage (P>0.05) in patients with
either PD or PDD.
FA and MD values in the genu of the corpus callosum
were significantly lower in patients with PDD than in those
with PD (P=0.0050, P=0.0013) or in normal controls (P=
0.0049, P = 0.00014) (Table 2). There were no significant
differences in diffusion in the genu of the corpus callosum
between PD patients and normal controls.
Discussion
Our study yielded three major findings. First, comparison of
patients with PDD with a group of healthy individuals
revealed diffusion abnormalities over a wide area of cerebral
white matter. Second, a comparison of PDD patients with PD
patients without dementia revealed diffusion abnormalities in
the anterior superior longitudinal fasciculus (i.e. the cerebral
white matter adjacent to the prefrontal area) and the genu of
the corpus callosum. Third, multiple linear regression analysis
Fig. 3 In PD and PDD patients,
TBSS analysis identified a
significant positive correlation
between FA and MMSE score.
(P<0.05, corrected for multiple
comparisons, gender and age at
the time of MRI). Red–yellow
voxels demonstrate a significant
correlation between the MMSE
score and FA
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of TBSS revealed a significant correlation between the
MMSE score and FA values of the cerebral white matter
adjacent to the prefrontal area and the genu of the corpus
callosum. Tract-specific analysis also detected a significant
correlation between the FA values of the genu of the corpus
callosum and the MMSE score, confirming the robustness of
our results.
The widespread deterioration of cerebral white matter in
the PDD group agrees with the results of the previous study
by Hattori et al. [14]. Although the pathological features of
white matter in PD are not well established, previous neu-
ropathological studies suggest that white-matter damage is a
multifaceted process. There are small Lewy abnormalities,
such as Lewy neurites and Lewy axons, in the cerebral white
matter in PD [5, 29]. Such accumulated Lewy abnormalities
may have altered the axonal structure, resulting in FA values
that were significantly lower in the major tracts in our PDD
patients than in the controls.
Our comparison between the PDD and PD groups also
revealed significant diffusion abnormalities in the genu of
the corpus callosum and the white matter adjacent to the
prefrontal area, uncovering a correlation between the MMSE
score and the diffusion abnormality in these domains. These
findings suggest that such changes could be used in assessing
the onset of dementia in patients with PD.
However, FA and MD did not correlate with MMSE score
in the separate PD and PDD groups when analysed by using
TBSS and TSA. When we included both the PD and the PDD
group combined, the FA values correlated positively with the
MMSE scores in almost the same white matter (prefrontal
white matter and genu of the corpus callosum) as that in which
FAwas decreased in PDD patients relative to PD patients. The
finding that PDD patients had significantly lower MMSE
scores than PD patients affected the result (FA values corre-
lated positively with MMSE scores in the prefrontal white
matter and the genu of the corpus callosum); however, the
smaller patient number in this subgroup (n=20, <40) may
have influenced this finding.
There were significant differences in disease duration,
Hoehn-Yahr stage, and levodopa dosage between the PD
Fig. 4 FA and MD values in the tracts of the genu of the corpus callosum in the PD and PDD patient groups combined were significantly correlated
with MMSE score (FA: r=0.472, P=0.002; MD: r=−0.453, P=0.003)
Table 2 Comparison of mean diffusivity (MD) and fractional anisotropy (FA) in the genu of the corpus callosum in patients and control subjects
CN PD PDD
GCC CN > PD CN > PDD PD > PDD
FA 0.52±0.03a 0.52±0.03 0.49±0.04 NS P<0.005c P<0.005c
CN < PD CN<PDD PD<PDD
MDb 1.01±0.07 1.04±0.08 1.13±0.10 NS P<0.00014c P<0.0013c
GCC genu of the corpus callosum, PD Parkinson’s disease, PDD Parkinson’s disease with dementia, CN control subjects
a Values are means ± standard deviation
b Diffusivity values are expressed as 10−3 mm2 /s
c Statistical significance (P<0.05)
1952 Eur Radiol (2013) 23:1946–1955
and PDD patients, and this may have affected the white
matter alterations in the PDD group. However, FA and
MD did not correlate with disease duration, Hoehn–Yahr
stage, or levodopa dosage in the PD and PDD groups. This
finding suggests that Hohen-Yahr stage, disease duration
and levodopa dosage have little influence on white matter
alteration compared with MMSE score.
The most consistent finding of structural MRI studies that
have compared PDD patients with normal individuals or
with PD patients has been atrophy of the entorhinal cortex,
hippocampus, prefrontal cortex and posterior cingulate gy-
rus [9–11]. In recent studies in particular, atrophy of the
white matter in the prefrontal area has been reported in
addition to atrophy of the prefrontal cortex [30]. The pattern
of atrophy of the entorhinal cortex, hippocampus and pos-
terior cingulate gyrus is similar to the pattern reported in
Alzheimer’s disease, suggesting that Alzheimer-like disease
abnormalities are part of the cause of the cognitive impair-
ment in PD [31, 32]. The atrophy of the prefrontal cortex
and white matter in PDD patients may also be related to the
presence of Lewy abnormalities of the cortex and white
matter. In fact, a neuropathological study has reported a link
between the number of Lewy bodies in the cortex and the
degree of dementia [33, 34]. In the Braak stages, the depo-
sition of Lewy bodies on the prefrontal cortex is classified as
Stage 5, which is a relatively early stage for the neocortex.
Neurite abnormalities, parallel with Lewy bodies, are also
found in PD [35]; these are called Lewy neuritis [36, 37].
Lewy abnormalities, such as Lewy neurites, are believed to
spread to the adjacent white matter in addition to the pre-
frontal cortex. These pathological changes may be a cause
of cognitive impairment in PD.
The corpus callosum is by far the largest fibre bundle in
the human brain, interconnecting the two cerebral hemi-
spheres with more than 300 million fibres and playing a
primary role in both high-level cognitive integration and
sensory integration [38]. Hofer and Frahm [27] defined five
vertical partitions of the corpus callosum. Region I, the most
anterior segment, covers the first sixth of the corpus cal-
losum and contains fibres that project into the prefrontal
region. The genu of the corpus callosum, which we defined
here as equivalent to Region I, contains fibres that project
into the prefrontal area [39]. In our study, the diffusion
abnormalities of the genu of the corpus callosum therefore
probably reflected prefrontal cortical Lewy abnormality and
prefrontal white-matter damage.
Hattori et al. [14] compared a PDD group with a PD
group and reported significant correlations between reduced
FA and MMSE score in the superior and inferior longitudi-
nal fasciculus, the lower frontal occipital fasciculus, the
uncinate fasciculus, the cingulate fasciculus and the corpus
callosum. They further reported significant correlations be-
tween the MMSE score and the decrease in FA values in the
same domains. An examination of the figures included in
their paper reveals that the alteration of the white matter was
found largely in the parietal lobe. This finding differs con-
siderably from our study results.
The difference between the results of our study and that
of Hattori et al. may reflect the fact that our study used 3-T
MRI and the diffusion tensor was imaged with a 32-axis
MPG. Examinations of Monte Carlo simulations are said to
require at least a 20-axis MPG to measure FA values and a
30-axis MPG to obtain more refined elements of the tensor
[40]. Furthermore, in vivo examinations are said to require a
21-axis MPG for the calculation of FA values [41]. Thus the
12-axis MPG used in the study by Hattori et al. does not
appear to meet these requirements; our study, which used a
32-axis MPG, may have produced more precise results. One
limitation of our study, however, is that our patient group
was smaller than that used by Hattori et al. Compared with
1.5-T MRI, 3-T MRI amplifies the distortion owing to the
unevenness of the magnetic field. However, it produces
high-resolution tensor images because of the increased
SNR and a reduction in noise-related errors [42]. Compared
with the PDD group in the report by Hattori et al. [14], our
PDD group had a somewhat lower MMSE score; this may
also have affected the results.
Hattori et al. reported significant correlations between
reduced FA and MMSE score in the parietal lobe bilaterally,
including in the precuneus; however, our results showed a
significant correlation between the FA value of only the left
side of the precuneus and the MMSE score. One possible
reason why the right precuneus did not produce the same
result could be that the FA changes in the precuneus were
small and at the threshold value, i.e. the limit of detection
(TFCE-corrected P<0.05). Figure 3 shows that major sec-
tions in the left precuneus are almost entirely red, indicating
the significant correlation between MMSE and FA. Another
possible reason why this change was found only on one side
is that our results may reflect the laterality of cognitive-
related white alterations. Hence, further studies are needed
to clarify whether cognitive impairment is associated with
laterality of white matter alterations.
We previously reported reduced FA in the anterior cin-
gulate fibre tracts in PD patients and a significant correlation
between FA in the anterior cingulate fibre tracts and MMSE
score by using tract-specific analysis in PDD patients [17].
In the present study, we detected reduced FA bilaterally in
the cingulate fibre tracts of PDD patients compared with in
normal controls, but we did not detect any reduced FA in PD
patients or a significant correlation between FA in the ante-
rior cingulate fibre tracts and MMSE score when we used
TBSS in PDD patients.
Compared with TSA, TBSS can influence the outcome
by multiple comparisons, whereas TSA has the advantage of
detecting abnormalities in specific white matter tracts.
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Therefore, our use of TBSS may have been the reason why
we did not detect reduced FA in the anterior cingulate fibre
tracts in PD patients.
The limitations of our study need to be addressed. Because
the diagnoses of PD and PDD were not histopathologically
confirmed, the possibility of misdiagnosis remains. However,
the validity of the diagnoses is supported by the finding that,
24 months or more after undergoing imaging, all of the patients
continued to respond satisfactorily to anti-parkinsonian therapy
and remained free of atypical parkinsonism.
In conclusion, we consider that the finding of diffusion
abnormalities in the cerebral white matter of PDD patients
reflects structural changes resulting from Lewy abnormali-
ties in the cerebral white matter. Our study also found a
relationship between cognitive impairment and alteration of
white matter adjacent to the prefrontal area and in the genu
of the corpus callosum. These changes may be useful in
assessing the onset of dementia in PD patients.
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